CoChat

An evaluation of variation in published estimates of schizophrenia prevalence from 1990–2013: A systematic literature review

Open access

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Abstract

BACKGROUND: There is a lack of consistency in findings across studies on the prevalence of schizophrenia, and no recent systematic review of the literature exists. The purpose of this study is to provide an updated systematic review of population-based prevalence estimates and to understand the factors that could account for this variation in prevalence estimates. METHODS: MEDLINE, Embase, and PsycInfo databases were searched for observational studies describing schizophrenia prevalence in general populations from 2003-2013 and supplemented by studies from a prior review covering 1990-2002. Studies reporting prevalence estimates from specialized populations such as institutionalized, homeless, or incarcerated persons were excluded. Prevalence estimates were compared both across and within studies by factors that might contribute to variability using descriptive statistics. RESULTS: Sixty-five primary studies were included; thirty-one (48 %) were from Europe and 35 (54 %) were conducted in samples of ≥50,000 persons. Among 21 studies reporting 12-month prevalence, the median estimate was 0.33 % with an interquartile range (IQR) of 0.26 %-0.51 %. The median estimate of lifetime prevalence among 29 studies was 0.48 % (IQR: 0.34 %-0.85 %). Prevalence across studies appeared to vary by study design, geographic region, time of assessment, and study quality scores; associations between study sample size and prevalence were not observed. Within studies, age-adjusted estimates were higher than crude estimates by 17 %-138 %, the use of a broader definition of schizophrenia spectrum disorders compared to schizophrenia increased case identification by 18 %-90 %, identification of cases from inpatient-only settings versus any setting decreased prevalence by 60 %, and no consistent trends were noted by differing diagnostic criteria. CONCLUSIONS: This review provides updated information on the epidemiology of schizophrenia in general populations, which is vital information for many stakeholders. Study characteristics appear to play an important role in the variation between estimates. Overall, the evidence is still sparse; for many countries no new studies were identified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12888-015-0578-7

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow diagram of study selection
Fig. 1 Flow diagram of study selectionCC BY · PubMed Central
Fig. 2 Prevalence of Schizophrenia in North America, Europe, Australia, and New Zealand. Countries are designated by 3-letter International Organization for Standardization (ISO) code. CAN: Canada; USA: United States; DNK: Denmark; FIN: Finland; IS: Iceland; IRL: Ireland; ITA: Italy; NLD: Netherlands; ESP: Spain; SWE: Sweden; GBR: United Kingdom; DEU: Germany; AUS: Australia; NZL: New Zealand. *Former West Germany
Fig. 2 Prevalence of Schizophrenia in North America, Europe, Australia, and New Zealand. Countries are designated by 3-letter International Organization for Standardization (ISO) code. CAN: Canada; USA: United States; DNK: Denmark; FIN: Finland; IS: Iceland; IRL: Ireland; ITA: Italy; NLD: Netherlands; ESP: Spain; SWE: Sweden; GBR: United Kingdom; DEU: Germany; AUS: Australia; NZL: New Zealand. *Former West GermanyCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 115 references

Research works printed but not linked: 2

  1. Vuylsteek K, Hallen M. Epidemiology. Amsterdam, Netherlands: Ios Press; 1994.
  2. Hovatta I, Terwilliger JD, Lichtermann D, Makikyro T, Suvisaari J, Peltonen L, et al. Schizophrenia in the genetic isolate of Finland. Am J Med Genet. 1997;74(4):353–60. · doi:10.1002/(sici)1096-8628(19970725)74:4<353::aid-ajmg3>3.0.co;2-q

Cited by

See all 352

Metadata

Authors
Simeone, J. C., Ward, A. J., Rotella, P., Collins, J., & Windisch, R.
Affiliations
F. Hoffmann-La Roche AG (CH)
Corresponding author
Simeone, Jason C.
Venue
BMC Psychiatry
Published
2015-08-12
Volume
15
Issue
1
Pages
193-193
ISSN
1471-244X (ISSN-L)
OpenAlex
W1906444297
Cited by
327
References
115
Citations by year
2026: 16 · 2025: 26 · 2024: 31 · 2023: 37 · 2022: 46 · 2021: 33 · 2020: 40 · 2019: 40 · 2018: 30 · 2017: 14 · 2016: 13 · 2015: 1
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
F. Hoffmann-La Roche
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, prevalence, 12-month prevalence, lifetime prevalence, research design, regional variation, age adjustment, case finding, diagnostic criteria, schizophrenia spectrum disorders, general population
MeSH terms
Europe, Humans, Schizophrenia, Time Factors, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An evaluation of variation in published estimates of schizophrenia prevalence from 1990–2013: A systematic literature review. https://app.cochat.ai/papers/10.1186/s12888-015-0578-7
The paper
Simeone, J. C., Ward, A. J., Rotella, P., Collins, J., & Windisch, R. (2015). An evaluation of variation in published estimates of schizophrenia prevalence from 1990–2013: A systematic literature review. BMC Psychiatry. https://doi.org/10.1186/s12888-015-0578-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.